HK1096875A1 - Compressed solid dosage form manufacturing processwell-suited for use with drugs of low aqueous sol ubility and compressed solid dosage forms made thereby - Google Patents

Compressed solid dosage form manufacturing processwell-suited for use with drugs of low aqueous sol ubility and compressed solid dosage forms made thereby

Info

Publication number
HK1096875A1
HK1096875A1 HK07104564A HK07104564A HK1096875A1 HK 1096875 A1 HK1096875 A1 HK 1096875A1 HK 07104564 A HK07104564 A HK 07104564A HK 07104564 A HK07104564 A HK 07104564A HK 1096875 A1 HK1096875 A1 HK 1096875A1
Authority
HK
Hong Kong
Prior art keywords
solid dosage
compressed solid
low aqueous
processwell
suited
Prior art date
Application number
HK07104564A
Other languages
English (en)
Inventor
Ilan Zalit
Fanny Leska
Mali Kadosh
Dorit Marco
Yonit Messer-Triger
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HK1096875A1 publication Critical patent/HK1096875A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07104564A 2004-11-10 2007-04-27 Compressed solid dosage form manufacturing processwell-suited for use with drugs of low aqueous sol ubility and compressed solid dosage forms made thereby HK1096875A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/037462 WO2006052254A2 (en) 2004-11-10 2004-11-10 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby

Publications (1)

Publication Number Publication Date
HK1096875A1 true HK1096875A1 (en) 2007-06-15

Family

ID=36218312

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104564A HK1096875A1 (en) 2004-11-10 2007-04-27 Compressed solid dosage form manufacturing processwell-suited for use with drugs of low aqueous sol ubility and compressed solid dosage forms made thereby

Country Status (11)

Country Link
EP (1) EP1729735B1 (ja)
JP (1) JP4842960B2 (ja)
AT (1) ATE365546T1 (ja)
AU (1) AU2004324858B2 (ja)
CA (1) CA2587295A1 (ja)
DE (1) DE602004007302T2 (ja)
DK (1) DK1729735T3 (ja)
HK (1) HK1096875A1 (ja)
IL (2) IL182549A (ja)
PT (1) PT1729735E (ja)
WO (1) WO2006052254A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2242483B1 (en) * 2007-12-21 2013-02-20 Synthon B.V. Raloxifene composition
US20110159084A1 (en) * 2008-04-02 2011-06-30 Dr. Reddy's Laboratories Ltd. Raloxifene pharmaceutical formulations
EP2448562B1 (en) 2009-07-02 2013-11-06 Synthon B.V. Raloxifene composition
EP3650010B1 (en) * 2018-11-09 2021-01-06 Siegfried AG Improved tableting process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
AU701042B2 (en) * 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
IL115357A (en) * 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
IL153441A0 (en) * 2000-06-16 2003-07-06 Teva Pharma Stable gabapentin having ph within a controlled range
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
DE602004007302T2 (de) 2008-03-20
DE602004007302D1 (de) 2007-08-09
AU2004324858B2 (en) 2009-12-10
JP2008519834A (ja) 2008-06-12
EP1729735B1 (en) 2007-06-27
IL182549A (en) 2010-11-30
IL182549A0 (en) 2007-09-20
EP1729735A2 (en) 2006-12-13
DK1729735T3 (da) 2007-10-08
JP4842960B2 (ja) 2011-12-21
WO2006052254A2 (en) 2006-05-18
WO2006052254A3 (en) 2006-08-17
PT1729735E (pt) 2007-08-06
CA2587295A1 (en) 2006-05-18
ATE365546T1 (de) 2007-07-15
AU2004324858A1 (en) 2006-05-18
IL200447A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
WO2004056363A3 (en) A physically and chemically stable nicotine-containing particulate material
WO2008035020A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
WO2004050058A3 (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
WO2007047948A3 (en) Intranasal administration of rapid acting insulin
MY151468A (en) Controlled release solid preparation
WO2008027854A3 (en) Pharmaceutical compositions comprising hgh for oral delivery
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
WO2008100240A3 (en) Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
HK1096875A1 (en) Compressed solid dosage form manufacturing processwell-suited for use with drugs of low aqueous sol ubility and compressed solid dosage forms made thereby
WO2007084212A3 (en) Biologically active composition comprising ethylcellulose
WO2008056375A3 (en) Pharmaceutical formulations comprising valsartan
WO2008062475A3 (en) Pharmaceutical compositions of ursodiol
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
RU2006145311A (ru) Твердая фармацевтическая композиция
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
CA2244097A1 (en) Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid
WO2007010369B1 (en) Sustained release formulation of alprazolam
WO2006081779A3 (en) A pharmaceutical composition containing olanzapine as the active agent and a process for the preparation thereof
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
ZA200705660B (en) Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate
WO2005004836A3 (en) Saquinavir mesylate oral dosage form

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101110